Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-02-20 @ 4:46 PM
Study NCT ID:
NCT01398904
Status:
COMPLETED
Last Update Posted:
2014-12-03
First Post:
2011-07-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Attentional Bias in Body Dysmorphic Disorder
Sponsor:
Massachusetts General Hospital
Organization:
Study Overview
Official Title:
Attentional Bias in Body Dysmorphic Disorder
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VAB
Brief Summary:
Body Dysmorphic Disorder (BDD) participants will demonstrate greater attentional biases as compared to healthy control (HC) participants. Greater attention bias will be associated with greater distress. Greater attention bias will be associated with greater symptom severity.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: